Research graph
References from Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus. Local targets link to admitted publications; unresolved targets remain external evidence.
Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000
10.1002/cncr.20364 · 2004 · External reference
Tumours of the anal canal
2000 · External reference
UKCCCR Anal Canal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C
10.1016/s0140-6736(96)03409-5 · 1996 · External reference
10.1200/jco.1997.15.5.2040
10.1200/jco.1997.15.5.2040 · 1997 · External reference
The role of mitomycin C in combination with 5-fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized Intergroup study
10.1200/jco.1996.14.9.2527 · 1996 · External reference
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: A randomized controlled trial
10.1001/jama.299.16.1914 · 2008 · External reference
Long-term update of US GI Intergroup RTOG 98-11 phase III trial for anal carcinoma: Disease-free and overall survival with RT+5-FU-mitomycin versus RT+5-FU-cisplatin
10.1200/jco.2011.29.15_suppl.4005 · 2011 · External reference
A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5-FU in squamous cell carcinoma of the anus (ACT II)
10.1200/jco.2009.27.18_suppl.lba4009 · 2009 · External reference
RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal
10.1016/j.ijrobp.2012.09.023 · 2013 · External reference
Unresolved reference
External reference
Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience
10.1016/j.ijrobp.2008.11.047 · 2009 · External reference
Predictions and patterns of recurrence after definitive chemoradiation for anal cancer
10.1016/j.ijrobp.2006.12.052 · 2007 · External reference
Squamous cell carcinoma of the anal canal: Patterns and predictors of failure and implications for intensity-modulated radiation treatment and planning
10.1016/j.ijrobp.2009.09.029 · 2010 · External reference
Role of positron emission tomography-computed tomography in the management of anal cancer
10.1016/j.ijrobp.2011.10.048 · 2012 · External reference
FDG-FDG PET/CT in the evaluation of anal carcinoma
10.1016/j.ijrobp.2006.01.009 · 2006 · External reference
Positron emission tomography/computed tomography in the staging and treatment of anal cancer
10.1016/j.ijrobp.2011.06.1955 · 2012 · External reference
Tumor response and survival predicted by post-therapy FDG-FDG - PET/CT in anal cancer
10.1016/j.ijrobp.2007.09.005 · 2008 · External reference
An application of changepoint methods in studying the effect of age on survival in breast cancer
10.1016/s0167-9473(98)00096-6 · 1999 · External reference
Unresolved reference
1981 · External reference
[18-F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small cell lung cancer
10.1200/jco.2005.06.129 · 2005 · External reference
Prognostic significance of SUV on FDG - PET/CT in patients with esophageal cancer: A systematic review and meta-analysis
10.1097/meg.0b013e328323d6fa · 2009 · External reference
Clinical utility of PET/CT in lymphoma
10.2214/ajr.09.2637 · 2010 · External reference
The influence of HPV-status on outcome of anal cancer treated with radio-chemotherapy
10.1016/j.ijrobp.2014.05.139 · 2014 · External reference
